Get started
Author

Katsuya Fujimoto

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
2014 · Michinori Ogura, Takashi Ishida, et al. · Journal of Clinical Oncology · 370
Differences in HIV Burden and Immune Activation within the Gut of HIV‐Positive Patients Receiving Suppressive Antiretroviral Therapy
2010 · Steven A. Yukl, Sara Gianella, et al. · The Journal of Infectious Diseases · 314
PDF
Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26
2007 · H. Gatanaga, T. Hayashida, et al. · Clinical Infectious Diseases · 223
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
2015 · Tomohiro Aoki, Ritsuro Suzuki, et al. · Blood · 141
Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma
2017 · M Fujisawa, M Sakata-Yanagimoto, et al. · Leukemia · 140
PDF
Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo
2012 · Satish K. Pillai, Mohamed Abdel-Mohsen, et al. · Proceedings of the National Academy of Sciences · 121
Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non‐Hodgkin lymphoma
2006 · Mitsufumi Nishio, Katsuya Fujimoto, et al. · European Journal Of Haematology · 61
PDF
Tumor necrosis factor-α inhibits generation of glycophorin A+ cells by CD34+ cells
2002 · Weiguo Xiao, Kazuki Koizumi, et al. · Experimental Hematology · 51
PDF
Bone Marrow Graft-versus-Host Disease: Evaluation of Its Clinical Impact on Disrupted Hematopoiesis after Allogeneic Hematopoietic Stem Cell Transplantation
2014 · Yusuke Shono, Souichi Shiratori, et al. · Transplantation and Cellular Therapy · 48
PDF
Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non‐Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation
2007 · Mitsufumi Nishio, Katsuya Fujimoto, et al. · British Journal of Haematology · 43
Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation
2017 · Naohiro Miyashita, Tomoyuki Endo, et al. · Transplant Infectious Disease · 41
PDF
Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia
2004 · T. Endo, N. Sato, et al. · American Journal of Hematology · 41
Prognosis by cancer type and incidence of zoledronic acid–related osteonecrosis of the jaw: a single-center retrospective study
2022 · Hironobu Hata, Kenji Imamachi, et al. · Supportive Care in Cancer · 37
PDF
A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma
2001 · T Endo, T Sakai, et al. · Bone Marrow Transplantation · 37
Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD
2011 · J Sugita, T Matsushita, et al. · Bone Marrow Transplantation · 34
PDF
Hepatitis B virus ( HBV ) reverse seroconversion ( RS ) can be prevented even in non‐responders to hepatitis B vaccine after allogeneic stem cell transplantation: long‐term analysis of intervention in RS with vaccine for patients with previous HBV infection
2014 · M. Takahata, S. Hashino, et al. · Transplant Infectious Disease · 33
Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome: RIC-HSCT for MF/SS
2014 · Souichi Shiratori, Katsuya Fujimoto, et al. · Hematological Oncology · 28
PDF
FCGR3A‐158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non‐Hodgkin’s lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation
2008 · Mitsufumi Nishio, Tomoyuki Endo, et al. · European Journal Of Haematology · 28
Stem cell factor protects c-kit+ human primary erythroid cells from apoptosis
2001 · Tomoyuki Endo, Atsushi Odb, et al. · Experimental Hematology · 28
PDF
Occurrence of adverse events caused by valganciclovir as pre‐emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low‐dose administration
2015 · M. Takahata, S. Hashino, et al. · Transplant Infectious Disease · 26
Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells
2011 · J Tanaka, J Sugita, et al. · Leukemia · 25
Peripheral blood stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin's lymphoma
2004 · T Endo, N Sato, et al. · Bone Marrow Transplantation · 23
Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes
2010 · Peilin Li, Theodore Ruel, et al. · Journal of Virological Methods · 19
Discrepancy between disease activity and levels of vascular endothelial growth factor in a patient with POEMS syndrome successfully treated with autologous stem-cell transplantation
2008 · H Goto, M Nishio, et al. · Bone Marrow Transplantation · 19
Exogenous and endogenous hyaluronic acid reduces HIV infection of CD4+ T cells
2014 · Peilin Li, Katsuya Fujimoto, et al. · Immunology and Cell Biology · 16
PDF
Works count: 109
Citation count: 2,328
H-index: 22
I10-index: 44
Year
Topic
Type